ATP6V0A4 | ATPase, H+ transporting, lysosomal V0 subunit a4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ATP6V0D2 | ATPase, H+ transporting, lysosomal 38kDa, V0 subunit d2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
ATP6V1G2 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G2 | Predicted intracellular proteins
| | | | | Tissue enriched |
ATP6V1G3 | ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G3 | Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
AUNIP | Aurora kinase A and ninein interacting protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
AXDND1 | Axonemal dynein light chain domain containing 1 | Predicted intracellular proteins
| | | | | Tissue enriched |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Group enriched |
AZU1 | Azurocidin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GAT1 | Beta-1,3-glucuronyltransferase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
B3GNT7 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7 | Predicted secreted proteins
| | | | | Tissue enhanced |
B4GALNT1 | Beta-1,4-N-acetyl-galactosaminyl transferase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
BAAT | Bile acid CoA:amino acid N-acyltransferase | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enriched |
BAG2 | BCL2-associated athanogene 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BANK1 | B-cell scaffold protein with ankyrin repeats 1 | Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
BARX2 | BARX homeobox 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BBOX1 | Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
BCAN | Brevican | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
BCAS1 | Breast carcinoma amplified sequence 1 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCL11B | B-cell CLL/lymphoma 11B (zinc finger protein) | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BEND2 | BEN domain containing 2 | Predicted intracellular proteins
| | | | | Tissue enriched |
BHLHA15 | Basic helix-loop-helix family, member a15 | Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
BHLHE22 | Basic helix-loop-helix family, member e22 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
BHMT2 | Betaine--homocysteine S-methyltransferase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Group enriched |
BIN1 | Bridging integrator 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
BIN2 | Bridging integrator 2 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
BOLL | Boule-like RNA-binding protein | Predicted intracellular proteins
| | | | | Tissue enriched |
BPI | Bactericidal/permeability-increasing protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
BPIFA1 | BPI fold containing family A, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFA2 | BPI fold containing family A, member 2 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFA3 | BPI fold containing family A, member 3 | Predicted secreted proteins
| | | | | Tissue enriched |
BPIFB1 | BPI fold containing family B, member 1 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BPIFB2 | BPI fold containing family B, member 2 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
BRSK1 | BR serine/threonine kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
BSND | Barttin CLCNK-type chloride channel accessory beta subunit | Disease related genes Predicted membrane proteins
| | | | | Tissue enriched |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BTLA | B and T lymphocyte associated | CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
BVES | Blood vessel epicardial substance | Predicted membrane proteins
| | | | | Tissue enhanced |
C10orf107 | Chromosome 10 open reading frame 107 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf126 | Chromosome 10 open reading frame 126 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf67 | Chromosome 10 open reading frame 67 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C10orf99 | Chromosome 10 open reading frame 99 | Predicted secreted proteins
| | | | | Group enriched |
C11orf42 | Chromosome 11 open reading frame 42 | Predicted intracellular proteins
| | | | | Tissue enriched |
C11orf70 | Chromosome 11 open reading frame 70 | Predicted intracellular proteins
| | | | | Group enriched |
C12orf56 | Chromosome 12 open reading frame 56 | Predicted intracellular proteins
| | | | | Tissue enriched |
C12orf60 | Chromosome 12 open reading frame 60 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C12orf77 | Chromosome 12 open reading frame 77 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C15orf48 | Chromosome 15 open reading frame 48 | Predicted intracellular proteins
| | | | | Tissue enhanced |